Tauriga Sciences Inc. Fully Repays its $135,000 Inventory Factoring Credit Facility, Entered Into on October 6, 2020
NEW YORK, NY, Sept. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today announced that it has fully repaid and retired its $135,000 Non-Convertible inventory factoring credit facility (the “Facility”), entered into with an institutional investor, on October 6, 2020. The Company repaid this Facility entirely in cash: for 5 equal installment payments of $21,214.29 and a final installment of $42,428.58. Due to the Company’s improved retail business, it decided to retire this Facility a month early. This $135,000 in factoring capital was structured as a non-convertible promissory note (interest bearing: 10.00% per annum), with a built in 6-month grace period. Repayment of this loan, contractually, was to occur in 7 equal monthly payments of $21,214.29 (Repayment Period: April 5, 2021 thru October 5, 2021).
- Link to Press Release from October 6, 2020
The Broker Dealer, Moody Capital, acted as the Placement Agent for this transaction. - Please visit our corporate website, for additional information, as well as inquiries, athttp://www.tauriga.com
Complementary to the Companys retail business, is its ongoing Pharmaceutical Development initiative. - Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.The Patent, filed with the U.S.P.T.O.
- On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.